Allied Market Research
Loading...
0
New
New
2021
Assisted Reproductive Technology Market

Assisted Reproductive Technology Market by Product (Instrument, Accessory & Disposable, and Reagent & Media), Technology (In Vitro-Fertilization, Artificial Insemination, and Others), and End User (Fertility Clinic, Hospital, Surgical Center, and Clinical Research Institute): Global Opportunity Analysis and Industry Forecast, 2021––2030

A13077
Pages: 310
Aug 2021 | 337 Views
   
Author(s) : Linu Dash , Onkar Sumant
Tables: 125
Charts: 38
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Assisted Reproductive Technology Market

Request Now !

The global assisted reproductive technology market size was valued at $2,317.7 million in 2020, and is estimated to reach $12,272.5 million by 2030, growing at a CAGR of 19.3% from 2021 to 2030. Assisted reproductive technology such as in vitro fertilization (IVF), artificial insemination (AI-IUI), and frozen embryo replacement, are used in the fertility clinics and surgical centers for the treatment of infertility.

Growth of the global assisted reproductive technology market is majorly driven by an increase in prevalence of infertility rate; rise in funding from private & government organizations for infertility services; rise in awareness regarding infertility treatment and surrogacy ; and increase in technology in the assisted reproductive technology. According to World Health Organization (WHO), in 2020, approximately 186 million individual and 48 million couple are diagnosed with infertility. According to Centers for Disease Control and Prevention (CDC), approximately 6% to 12% of the U.S. women suffering from PCOS were also diagnosed with infertility disorder. Thus, increase in prevalence of PCOS, surge the risk for infertility and drive the growth of assisted reproductive technology market. For instance, in February 2021, TMRW Life Sciences, a life science technology company providing platform for tracking and monitoring, announced the launch of world’s first automated cryo specimen management solution for eggs and embryo, which are used in the IVF procedure. Thus, the technological advancement features the use of software and imaging system in order to check the growth of embryo on the monitors. Moreover, in 2018, LUMSA University, in Italy, announced the WoMoGeS (Women’s movement and gestational surrogacy) project, which aims to raise awareness on gestational surrogacy among the vulnerable women in developing countries. Furthermore, the presence of emerging key players in assisted reproductive technologies and rise in disposable income propel the growth of the market.

Assisted-Reproductive-Technology-market

Get more information on this report : Request Sample Pages

However, high cost of assisted reproductive technology (ART) procedure and risk associated with in vitro fertilization treatment are expected to restrict the market growth during the forecast period.

Assisted Reproductive Technology Market Segmentation

The assisted reproductive technology market is segmented on the basis of product, technology, end user, and region. By product, the market is categorized into instrument, accessory & disposable and reagent & media. The instrument segment is further classified into sperm separation system, cryosystem, incubator, imaging system, ovum aspiration pump, cabinet, micromanipulator, laser systems, and others. The reagent & media segment is further divided into cryopreservation media, semen processing media, ovum processing media, and embryo culture media. 

By technology, it is divided into in vitro fertilization, artificial insemination, and others. By end user, the market is fragmented into fertility clinic, hospital, surgical center, and clinical research institute.

Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Segment review

Depending on product, the accessory & disposable segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in prevalence of infertility, surge in demand for in vitro fertilization procedure such as retrieval of oocytes, analysis & screening of sperms, handling gametes, and others. However, the reagent & media segment is expected to witness considerable market growth during the forecast period, owing to increase in demand for frozen embryo transfer, rise in prevalence of infertility, and surge in number of IVF procedures.

Assisted Reproductive Technology Market
By Product

Your browser does not support the canvas element.

Accessory & Disposable segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

On the basis of technology, the in-vitro fertilization segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to decrease in fertility rate, surge in sedentary lifestyle, increase in trend of delayed pregnancy and low cost of IVF procedure. However, the artificial insemination segment is expected to witness considerable growth during the forecast period, owing to surge in the number of investments in digital infrastructure and rise in demand for software upgrade and installation.

Assisted Reproductive Technology Market
By Technology

Your browser does not support the canvas element.

In Vitro-Fertilization (IVF) segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

On the basis of end user, the fertility clinic segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in prevalence of fertility cases, the surge in sedentary lifestyle, and growth in number of fertility clinics. However, the surgical center segment is expected to witness considerable growth during the forecast period, owing to increase in number of infertility surgical procedure and surge in demand for in-vitro fertilization.

Assisted Reproductive Technology Market
By End User

Your browser does not support the canvas element.

Fertility clinic segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Europe accounted for a major share in the assisted reproductive technology market in 2020, and is expected to maintain its dominance during the forecast period, due to increase in utilization of novel technology equipment service, rise in incidence of infertility cases, high disposable incomes, rise of funds from government and private organization for in-vitro fertilization (IVF), and advancements in technology for infertility in the region. However, Asia-Pacific is expected to register highest CAGR of 21.3% from 2021 to 2030, owing to increase in incidence of infertility cases, rise in awareness about surrogacy, and increase in demand for assisted reproductive technology.

Assisted Reproductive Technology Market
By Region

2030
Europe 
North America
Asia-pacific
Lamea

Europe was holding a dominant position in 2020 and would continue to maintain the lead over the analysis period.

Get more information on this report : Request Sample Pages

Key players operating in the global assisted reproductive technology market include Cook Medical Inc., Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.), Genea Biomedx, Merck KGaA (EMD Serono, Inc.), Millendo Therapeutics, Inc., Oxford Gene Technology, Progyny Inc., The Cooper Companies, Inc. (CooperSurgical, Inc.), Thermo Fisher Scientific, Inc., Vitrolife AB.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the assisted reproductive technology market, and the current trends and future estimations to elucidate imminent investment pockets.
  • It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the assisted reproductive technology market.

Key Market Segments

By Product 

  • Instrument
    • Sperm Separation System
    • Cryosystem
    • Incubator
    • Imaging System
    • Ovum Aspiration Pump
    • Cabinet
    • Micromanipulator
    • Laser Systems
    • Others
  • Accessory & Disposable
  • Reagents & Media
    • Cryopreservation Media
    • Semen Processing Media
    • Ovum Processing Media
    • Embryo Culture Media

By Technology

  • In Vitro-Fertilization
  • Artificial Insemination
  • Others

By End User

  • Fertility Clinic
  • Hospital
  • Surgical Center
  • Clinical Research Institute

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

KEY MARKET PLAYERS 

  • Cook Medical Inc.
  • Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.)
  • Genea Biomedx
  • Merck KGaA (EMD Serono, Inc.)
  • Millendo Therapeutics, Inc.
  • Oxford Gene Technology
  • Progyny Inc.
  • The Cooper Companies, Inc. (CooperSurgical, Inc.)
  • Thermo Fisher Scientific, Inc. 
  • Vitrolife AB
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in prevalence of infertility rate
3.5.1.2.Technological advancements in assisted reproductive technology
3.5.1.3.Growth in disposable income and rise in awareness regarding infertility treatment

3.5.2.Restraint

3.5.2.1.High cost of ART procedure
3.5.2.2.Risk associated with IVF treatment

3.5.3.Opportunity

3.5.3.1.Growing opportunities in emerging market and rise in fertility tourism

3.5.4.Impact analysis

3.6.Impact analysis of COVID-19 on the assisted reproductive technology market

CHAPTER 4:ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Instrument

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Instrument, by type

4.2.2.1.Market size and forecast
4.2.2.2.Sperm separation system

4.2.2.2.1.Market size and forecast

4.2.2.3.Cryosystem

4.2.2.3.1.Market size and forecast

4.2.2.4.Incubator

4.2.2.4.1.Market size and forecast

4.2.2.5.Imaging system

4.2.2.5.1.Market size and forecast

4.2.2.6.Ovum aspiration pump

4.2.2.6.1.Market size and forecast

4.2.2.7.Cabinet

4.2.2.7.1.Market size and forecast

4.2.2.8.Micromanipulator

4.2.2.8.1.Market size and forecast

4.2.2.9.Laser systems

4.2.2.9.1.Market size and forecast

4.2.2.10.Others

4.2.2.10.1.Market size and forecast

4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country

4.3.Accessory & Disposable

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

4.4.Reagent & Media

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Reagent & Media, by type

4.4.2.1.Market size and forecast
4.4.2.2.Cryopreservation Media

4.4.2.2.1.Market size and forecast

4.4.2.3.Semen processing media

4.4.2.3.1.Market size and forecast

4.4.2.4.Ovum processing media

4.4.2.4.1.Market size and forecast

4.4.2.5.Embryo culture media

4.4.2.5.1.Market size and forecast

4.4.3.Market size and forecast, by region
4.4.4.Market analysis, by country

CHAPTER 5:ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TECHNOLOGY

5.1.Overview

5.1.1.Market size and forecast

5.2.In vitro-fertilization

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Artificial Insemination

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country

5.4.Others

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country

CHAPTER 6:ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Fertility clinics

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country

6.3.Hospital

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country

6.4.Surgical center

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country

6.5.Clinical research institute

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by region
6.5.3.Market analysis, by country

CHAPTER 7:ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast'

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America  assisted reproductive technology  market, by product
7.2.3.North America  assisted reproductive technology  market, by technology
7.2.4.North America  assisted reproductive technology  market, by end user
7.2.5.Market size and forecast, by country

7.2.5.1.U.S.

7.2.5.1.1.U.S. assisted reproductive technology  market, by product
7.2.5.1.2.U.S. assisted reproductive technology  market, by technology
7.2.5.1.3.U.S. assisted reproductive technology  market, by end user

7.2.5.2.Canada

7.2.5.2.1.Canada assisted reproductive technology  market, by product
7.2.5.2.2.Canada assisted reproductive technology  market, by technology
7.2.5.2.3.Canada assisted reproductive technology  market, by end user

7.2.5.3.Mexico

7.2.5.3.1.Mexico assisted reproductive technology  market, by product
7.2.5.3.2.Mexico assisted reproductive technology  market, by technology
7.2.5.3.3.Mexico assisted reproductive technology  market, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe assisted reproductive technology  market, by product
7.3.3.Europe assisted reproductive technology  market, by technology
7.3.4.Europe assisted reproductive technology  market, by end user
7.3.5.Market size and forecast, by country

7.3.5.1.Germany

7.3.5.1.1.Germany assisted reproductive technology  market, by product
7.3.5.1.2.Germany assisted reproductive technology  market, by technology
7.3.5.1.3.Germany assisted reproductive technology  market, by end user

7.3.5.2.France

7.3.5.2.1.France assisted reproductive technology  market, by product
7.3.5.2.2.France assisted reproductive technology  market, by technology
7.3.5.2.3.France assisted reproductive technology  market, by end user

7.3.5.3.UK

7.3.5.3.1.UK assisted reproductive technology  market, by product
7.3.5.3.2.UK assisted reproductive technology  market, by technology
7.3.5.3.3.UK assisted reproductive technology  market, by end user

7.3.5.4.Italy

7.3.5.4.1.Italy assisted reproductive technology  market, by product
7.3.5.4.2.Italy assisted reproductive technology  market, by technology
7.3.5.4.3.Italy assisted reproductive technology  market, by end user

7.3.5.5.Spain

7.3.5.5.1.Spain assisted reproductive technology  market, by product
7.3.5.5.2.Spain assisted reproductive technology  market, by technology
7.3.5.5.3.Spain assisted reproductive technology  market, by end user

7.3.5.6.Rest of Europe

7.3.5.6.1.Rest of Europe assisted reproductive technology  market, by product
7.3.5.6.2.Rest of Europe assisted reproductive technology  market, by technology
7.3.5.6.3.Rest of Europe assisted reproductive technology  market, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific assisted reproductive technology  market, by product
7.4.3.Asia-Pacific assisted reproductive technology  market, by technology
7.4.4.Asia-Pacific assisted reproductive technology  market, by end user
7.4.5.Market size and forecast, by country

7.4.5.1.Japan

7.4.5.1.1.Japan assisted reproductive technology  market, by product
7.4.5.1.2.Japan assisted reproductive technology  market, by technology
7.4.5.1.3.Japan assisted reproductive technology  market, by end user

7.4.5.2.China

7.4.5.2.1.China assisted reproductive technology  market, by product
7.4.5.2.2.China assisted reproductive technology  market, by technology
7.4.5.2.3.China assisted reproductive technology  market, by end user

7.4.5.3.India

7.4.5.3.1.India assisted reproductive technology  market, by product
7.4.5.3.2.India assisted reproductive technology  market, by technology
7.4.5.3.3.India assisted reproductive technology  market, by end user

7.4.5.4.Australia

7.4.5.4.1.Australia assisted reproductive technology  market, by product
7.4.5.4.2.Australia assisted reproductive technology  market, by technology
7.4.5.4.3.Australia assisted reproductive technology  market, by end user

7.4.5.5.South Korea

7.4.5.5.1.South Korea assisted reproductive technology  market, by product
7.4.5.5.2.South Korea assisted reproductive technology  market, by technology
7.4.5.5.3.South Korea assisted reproductive technology  market, by end user

7.4.5.6.Rest of Asia-Pacific

7.4.5.6.1.Rest of Asia-Pacific assisted reproductive technology  market, by product
7.4.5.6.2.Rest of Asia-Pacific assisted reproductive technology  market, by technology
7.4.5.6.3.Rest of Asia-Pacific assisted reproductive technology  market, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA assisted reproductive technology  market, by product
7.5.3.LAMEA assisted reproductive technology  market, by technology
7.5.4.LAMEA assisted reproductive technology  market, by end user
7.5.5.Market size and forecast, by country

7.5.5.1.Brazil

7.5.5.1.1.Brazil assisted reproductive technology  market, by product
7.5.5.1.2.Brazil assisted reproductive technology  market, by technology
7.5.5.1.3.Brazil assisted reproductive technology  market, by end user

7.5.5.2.Saudi Arabia

7.5.5.2.1.Saudi Arabia assisted reproductive technology  market, by product
7.5.5.2.2.Saudi Arabia assisted reproductive technology  market, by technology
7.5.5.2.3.Saudi Arabia assisted reproductive technology  market, by end user

7.5.5.3.South Africa

7.5.5.3.1.South Africa assisted reproductive technology  market, by product
7.5.5.3.2.South Africa assisted reproductive technology  market, by technology
7.5.5.3.3.South Africa assisted reproductive technology  market, by end user

7.5.5.4.Rest of LAMEA

7.5.5.4.1.Rest of LAMEA assisted reproductive technology  market, by product
7.5.5.4.2.Rest of LAMEA assisted reproductive technology  market, by technology
7.5.5.4.3.Rest of LAMEA assisted reproductive technology  market, by end user

CHAPTER 8:COMPANY PROFILES

8.1.COOK GROUP

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Key strategic moves and developments

8.2.FUJIFILM HOLDINGS CORPORATION

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments

8.3.GENEA BIOMEDX

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Key strategic moves and developments

8.4.MERCK KGAA

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments

8.5.INCEPTION SCIENCES, INC.

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio

8.6.OXFORD GENE TECHNOLOGY IP LTD.

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio

8.7.PROGYNY INC.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance

8.8.THE COOPER COMPANIES, INC.

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments

8.9.THERMO FISHER SCIENTIFIC, INC.

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance

8.10.VITROLIFE AB

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments

LIST OF TABLES

TABLE 01.GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 02.INSTRUMENT MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 03.INSTRUMENT ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 04.ACCESSORY & DISPOSABLE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 05.REAGENT & MEDIA MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 06.REAGENT & MEDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 07.GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 08.IN VITRO-FERTILIZATION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 09.ARTIFICIAL INSEMINATION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 10.OTHERS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 11.GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 12.ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR FERTILITY CLINIC, BY REGION, 2020-2030 ($MILLION)
TABLE 13.HOSPITAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 14.SURGICAL CENTER ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2020-2030 ($MILLION)
TABLE 15.CLINICAL RESEARCH INSTITUTE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 16.ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 17.NORTH AMERICA  ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 18.NORTH AMERICA  ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 19.NORTH AMERICA  ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 20.NORTH AMERICA  ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 21.U.S. ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 22.U.S. ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 23.U.S. ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 24.CANADA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 25.CANADA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 26.CANADA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 27.MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 28.MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 29.MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 30.EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 31.EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 32.EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 33.EUROPE  ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 34.GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 35.GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 36.GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 37.FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 38.FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 39.FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 40.UK ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 41.UK ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 42.UK ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 43.ITALY ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 44.ITALY ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 45.ITALY ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 46.SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 47.SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 48.SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 49.REST OF EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 50.REST OF EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 51.REST OF EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 52.ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 53.ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 54.ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 55.ASIA-PACIFIC  ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 56.JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 57.JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 58.JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 59.CHINA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 60.CHINA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 61.CHINA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 62.INDIA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 63.INDIA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 64.INDIA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 65.AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 66.AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 67.AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 68.SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 69.SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 70.SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 71.REST OF ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 72.REST OF ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 73.REST OF ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 74.LAMEA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 75.LAMEA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 76.LAMEA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 77.LAMEA  ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 78.BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 79.BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 80.BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 81.SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 82.SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 83.SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 84.SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 85.SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 86.SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 87.REST OF LAMEA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 88.REST OF LAMEA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 89.REST OF LAMEA ASSISTED REPRODUCTIVE TECHNOLOGY  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 90.COOK: COMPANY SNAPSHOT
TABLE 91.COOK: OPERATING SEGMENTS
TABLE 92.COOK: PRODUCT PORTFOLIO
TABLE 93.COOK: KEY DEVELOPMENTS
TABLE 94.FUJIFILM: COMPANY SNAPSHOT
TABLE 95.FUJIFILM: OPERATING BUSINESS SEGMENTS
TABLE 96.FUJIFILM: PRODUCT PORTFOLIO
TABLE 97.FUJIFILM: KEY DEVELOPMENTS
TABLE 98.GENEA: COMPANY SNAPSHOT
TABLE 99.GENEA: PRODUCT SEGMENTS
TABLE 100.GENEAE: PRODUCT PORTFOLIO
TABLE 101.GENEA: KEY DEVELOPMENTS
TABLE 102.MERCK: COMPANY SNAPSHOT
TABLE 103.MERCK: OPERATING SEGMENTS
TABLE 104.MERCK: PRODUCT PORTFOLIO
TABLE 105.MERCK: KEY DEVELOPMENTS
TABLE 106.INCEPTION: COMPANY SNAPSHOT
TABLE 107.INCEPTION: OPERATING SEGMENTS
TABLE 108.INCEPTION: PRODUCT PORTFOLIO
TABLE 109.OXFORD: COMPANY SNAPSHOT
TABLE 110.OXFORD: OPERATING BUSINESS SEGMENTS
TABLE 111.OXFORD: PRODUCT PORTFOLIO
TABLE 112.PROGYNY: COMPANY SNAPSHOT
TABLE 113.PROGYNY: OPERATING SEGMENTS
TABLE 114.PROGYNY: PRODUCT PORTFOLIO
TABLE 115.COOPER: COMPANY SNAPSHOT
TABLE 116.COOPER: OPERATING SEGMENTS
TABLE 117.COOPER: PRODUCT PORTFOLIO
TABLE 118.COOPER: KEY DEVELOPMENTS
TABLE 119.THERMO FISHER: COMPANY SNAPSHOT
TABLE 120.THERMO FISHER: OPERATING SEGMENTS
TABLE 121.THERMO FISHER: PRODUCT PORTFOLIO
TABLE 122.VITROLIFE: COMPANY SNAPSHOT
TABLE 123.VITROLIFE: OPERATING SEGMENTS
TABLE 124.VITROLIFE: PRODUCT PORTFOLIO
TABLE 125.VITROLIFE: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 01.ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF INSTRUMENT ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR ACCESSORY & DISPOSABLE, BY COUNTRY, 2020-2030 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF REAGENT & MEDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF IN VITRO-FERTILIZATION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF ARTIFICIAL INSEMINATION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF OTHERS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR FERTILITY CLINIC, BY COUNTRY, 2020-2030 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR HOSPITAL, BY COUNTRY, 2020-2030 (%)
FIGURE 21.COMPARATIVE ANALYSIS OF ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR SURGICAL CENTER, BY COUNTRY,  2020-2030 (%)
FIGURE 22.COMPARATIVE ANALYSIS OF ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CLINICAL RESEARCH INSTITUTE, BY COUNTRY, 2020-2030 (%)
FIGURE 23.FUJIFILM: NET SALES, 2019–2021 ($MILLION)
FIGURE 24.FUJIFILM: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 25.FUJIFILM: REVENUE SHARE BY REGION, 2021(%)
FIGURE 26.MERCK: NET SALES, 2018–2020 ($MILLION)
FIGURE 27.MERCK: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 28.MERCK: REVENUE SHARE BY REGION, 2020(%)
FIGURE 29.PROGYNY: NET SALES, 2018–2020 ($MILLION)
FIGURE 30.COOPER: NET SALES, 2018–2020 ($MILLION)
FIGURE 31.COOPER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32.COOPER: REVENUE SHARE BY REGION, 2020(%)
FIGURE 33.THERMO FISHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 34.THERMO FISHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 35.THERMO FISHER: REVENUE SHARE BY REGION, 2020(%)
FIGURE 36.VITROLIFE: NET SALES, 2018–2020 ($MILLION)
FIGURE 37.VITROLIFE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 38.VITROLIFE: REVENUE SHARE BY REGION, 2020(%)

 
 

Growth of the assisted reproductive technology market is attributed to factors such as technological advancements in in-vitro fertilization (IVF) devices; rise in prevalence of polycystic ovarian syndrome (PCOD); increase in incidence of infertility cases, and surge in demand for the IVF procedure. The assisted reproductive technology market gains interest of biotechnology and pharmaceutical companies, owing to surge in demand for cryopreservation media, embryo culture media, ovum aspiration pump, sperm separation system, laser assisted hatching, which are used for the treatment of infertility. This leads to increase in adoption of various procedure for the treatment of infertility. Moreover, the market has gained high traction in assisted reproductive technology, such as artificial insemination, in-vitro fertilization, and frozen embryo replacement, in recent years as assisted reproductive technology procedures are used in treatment of infertility. 

Further, Europe is expected to witness highest growth, in terms of revenue, owing to increase in utilization of novel technology equipment service, rise in incidence of infertility cases, high disposable incomes, rise of funds from government and private organization for in-vitro fertilization (IVF), and advancements in technology for infertility.

Asia-Pacific was the second largest contributor to the market in 2020, and is expected to register the fastest CAGR during the forecast period, owing to increase in incidence of infertility cases, rise in awareness about surrogacy, and increase in demand for assisted reproductive technology.

In addition, high cost associated with ART and risk after the IVF procedure are anticipated to restrain the market growth during the forecast period.
 

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of assisted reproductive technology Market is $2,317.7 million in 2020.

A. The forecast period in the report is from 2021 to 2030

A. The market value of assisted reproductive technology Market in 2021 was $2,500.8 million

A. The base year for the report is 2020.

A. Yes, assisted reproductive technology companies are profiled in the report

A. The top companies that hold the market share in assisted reproductive technology market are Cook Medical Inc., Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.), Genea Biomedx, Merck KGaA (EMD Serono, Inc.), Millendo Therapeutics, Inc., Oxford Gene Technology, Progyny Inc., The Cooper Companies, Inc. (CooperSurgical, Inc. Thermo Fisher Scientific, Inc., Vitrolife AB.

A. No, there is no value chain analysis provided in the assisted reproductive technology Market report

A. The key trends in the assisted reproductive technology Market are alarming increase in the prevalence of polycystic ovary syndrome, rise in disposable income, surge in demand for in vitro-fertilization, advancement in the technology for novel ART, and a rise in awareness about IVF and surrogacy.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Assisted Reproductive Technology Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers